Peer-reviewed veterinary case report
Vision loss in a 29-month-old German Shepherd from optic nerve tumor
By Lunking, Vienna M et al.·Published in Veterinary ophthalmology·2026·Department of Clinical Sciences, United States·View original on PubMed →
PetCaseFinder translated the abstract of this peer-reviewed paper into plain English so pet owners can read it. We do not publish original research — every detail traces back to the citation above. How we work →
Original publication title: Optic Chiasm and Bilateral Optic Nerve Oligodendroglioma in A 29-Month-Old German Shepherd.
- Species:
- dog
Plain-English summary
A 29-month-old male German Shepherd was brought to the vet due to vision problems caused by a large tumor affecting his optic nerves. Over two months, the dog underwent various tests, including MRIs and a biopsy, which revealed a high-grade oligodendroglioma, a type of brain tumor. Unfortunately, despite the efforts to diagnose and understand the tumor, the dog passed away, and further examination confirmed the aggressive nature of the cancer. This case highlights the rarity of such tumors in dogs and the need for more research into treatment options.
People also search for: dog vision problems · German Shepherd brain tumor · oligodendroglioma in dogs treatment
Abstract
OBJECTIVE: To report the first documented case of high-grade optic chiasm and nerve oligodendroglioma in a young dog and contribute to the comparative study of gliomas in humans and canines. ANIMAL STUDIED: A 29-month-old male intact German Shepherd. PROCEDURES: Over 2 months, the patient underwent repeated physical and ophthalmic examinations, systemic health assessments (complete blood count, serum biochemistry, urinalysis, and infectious disease testing), anesthetized MRI, ultrasound-guided biopsy of the left retrobulbar mass, and necropsy. Histopathologic and immunohistochemical analyses, including OLIG2 and GFAP immunohistochemistry, were performed. RESULTS: MRI evaluation identified a large, lobulated, asymmetric mass with retrobulbar involvement and compression of the optic chiasm and optic nerves. The mass exhibited hyperintense signals on T2-weighted and T2-FLAIR sequences, mixed intensity on T1-weighted imaging, and heterogeneous contrast enhancement, with areas of necrosis and meningeal enhancement suggestive of an aggressive neoplasm. Gross necropsy findings and histopathologic examination of post-mortem tissues confirmed the diagnosis of a high-grade oligodendroglioma, with tumor cells demonstrating marked nuclear atypia, high mitotic activity, and OLIG2 nuclear immunoreactivity. CONCLUSIONS: The tumor's localization and histological characteristics suggested a primary origin within the optic pathway, differing from typical canine oligodendrogliomas. This case emphasizes the rarity of canine optic pathway oligodendrogliomas, a diagnosis that is similarly uncommon in human medicine. Dogs have been proposed as an intermediate animal model for human gliomas, and this case underscores the need for further molecular characterization of canine gliomas to improve diagnostic accuracy, therapeutic strategies, and comparative oncology insights.
Find similar cases for your pet
PetCaseFinder finds other peer-reviewed reports of pets with the same symptoms, plus a plain-English summary of what was tried across them.
Search related cases →Original publication on PubMed: https://pubmed.ncbi.nlm.nih.gov/40846656/